Orchestra BioMed
OBIO
OBIO
53 hedge funds and large institutions have $129M invested in Orchestra BioMed in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3.1% more ownership
Funds ownership: 59.66% → 62.75% (+3.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
53
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.26M | |
| 2 | +$1.8M | |
| 3 | +$1.7M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.48M |
| 5 |
HI
HBK Investments
Dallas,
Texas
|
+$620K |
Top Sellers
| 1 | -$3.93M | |
| 2 | -$1.95M | |
| 3 | -$215K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$173K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$90.8K |